Renaissance Technologies
CCXI

Renaissance Technologies’s ChemoCentryx, Inc. CCXI Stock Holding History

Renaissance Technologies’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-66,100
Closed -$4.09M – 3849
2020
Q4 		$4.09M Buy
+66,100
New +$3.78M ﹤0.01% 1717
2020
Q3 		– Sell
-265,100
Closed -$15.3M – 3799
2020
Q2 		$15.3M Sell
265,100
-58,200
-18% -$3.17M 0.01% 977
2020
Q1 		$13M Sell
323,300
-445,281
-58% -$18.9M 0.01% 1002
2019
Q4 		$30.4M Sell
768,581
-527,398
-41% -$9.26M 0.02% 771
2019
Q3 		$8.79M Sell
1,295,979
-169,402
-12% -$1.27M 0.01% 1467
2019
Q2 		$13.6M Buy
1,465,381
+332,127
+29% +$3.84M 0.01% 1202
2019
Q1 		$15.7M Buy
1,133,254
+249,873
+28% +$2.86M 0.01% 1104
2018
Q4 		$9.64M Buy
883,381
+111,100
+14% +$1.17M 0.01% 1330
2018
Q3 		$9.76M Buy
772,281
+52,800
+7% +$636K 0.01% 1375
2018
Q2 		$9.48M Sell
719,481
-49,800
-6% -$596K 0.01% 1384
2018
Q1 		$10.5M Sell
769,281
-94,300
-11% -$973K 0.01% 1337
2017
Q4 		$5.14M Sell
863,581
-63,300
-7% -$434K 0.01% 1790
2017
Q3 		$6.88M Buy
926,881
+203,730
+28% +$1.69M 0.01% 1553
2017
Q2 		$6.77M Buy
723,151
+106,570
+17% +$782K 0.01% 1501
2017
Q1 		$4.49M Buy
616,581
+146,000
+31% +$1.05M 0.01% 1747
2016
Q4 		$3.48M Buy
470,581
+272,600
+138% +$1.96M 0.01% 1905
2016
Q3 		$1.2M Buy
197,981
+128,300
+184% +$606K ﹤0.01% 2481
2016
Q2 		$313K Sell
69,681
-99,373
-59% -$373K ﹤0.01% 2935
2016
Q1 		$421K Buy
169,054
+124,754
+282% +$454K ﹤0.01% 2888
2015
Q4 		$359K Buy
44,300
+19,600
+79% +$139K ﹤0.01% 2834
2015
Q3 		$149K Sell
24,700
-102,677
-81% -$742K ﹤0.01% 2948
2015
Q2 		$1.05M Buy
127,377
+45,677
+56% +$363K ﹤0.01% 2426
2015
Q1 		$617K Buy
81,700
+17,777
+28% +$139K ﹤0.01% 2524
2014
Q4 		$437K Sell
63,923
-4,377
-6% -$23.1K ﹤0.01% 2476
2014
Q3 		$307K Buy
68,300
+13,400
+24% +$70.8K ﹤0.01% 2466
2014
Q2 		$321K Sell
54,900
-144,880
-73% -$813K ﹤0.01% 2459
2014
Q1 		$1.32M Sell
199,780
-188,100
-48% -$1.31M ﹤0.01% 1953
2013
Q4 		$2.25M Buy
+387,880
New +$2M 0.01% 1693

Other funds holding CCXI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Renaissance Technologies's CCXI Position: Q1 2021 in Review

Renaissance Technologies sold out of ChemoCentryx, Inc. (CCXI) in Q1 2021, closing a stake of 66,100 shares — an estimated $4.09M sold.

Renaissance Technologies first reported a position in CCXI in Q4 2013 and held it in 28 quarters. The position peaked at $30.4M in Q4 2019. 183 funds tracked by Wall St. Rank hold CCXI as of Q1 2021.

  • Renaissance Technologies reported no remaining ChemoCentryx, Inc. position as of Q1 2021 after selling out during the quarter.
  • Renaissance Technologies sold 66,100 ChemoCentryx, Inc. shares in Q1 2021, an estimated $4.09M.
  • Renaissance Technologies first reported a position in ChemoCentryx, Inc. in Q4 2013 and held it in 28 quarters.
  • Renaissance Technologies's ChemoCentryx, Inc. position peaked at $30.4M in Q4 2019.
  • 183 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q1 2021.

Based on Renaissance Technologies's 13F filing for Q1 2021, filed 13 May 2021.